Enter your login e-mail to the account
Search
- THE ROLE OF PET/CT IN DIAGNOSIS AND TREATMENT STRATEGY OF MALIGNANT LYMPHOMA
MUDr. Pavol Povinec, PhD.
(2/2008, Review articles ) - Brentuximab vedotin for the treatment of patients with Hodgkin lymphoma
doc. MUDr. Juraj Sokol, PhD., MUDr. Juraj Chudej, PhD., MUDr. Anna Chbat, MUDr. Ľudmila Lineková, MUDr. Monika Péčová, MUDr. Lenka Lisá, PhD., Prof. MUDr. Ján Staško, PhD.
(1/2022, Drugs & drug classes ) - Classical and new prognostic factors and their impact on therapeutic procedures in DLBCL
doc. MUDr. Igor Andrašina, CSc., MUDr. Martin Petrilák
(3/2015, Spectrum ) - Checkpoint inhibitors in treatment of malignant lymphoma
MUDr. Barbora Kašperová
(3/2019, Review articles ) - Relapsed/refractory diffuse large B-cell lymphoma
MUDr. Miriam Ladická
(4/2015, Spectrum ) - Diffuse large B-cell lymphoma in atypical locations
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2015, Spectrum ) - The current status of biological therapy for relapsed/refractory classical hodgkin lymphoma – a case report
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Ľubica Váleková, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(2/2015, Original articles & case reports )